vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and WESBANCO INC (WSBC). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $257.2M, roughly 1.5× WESBANCO INC). WESBANCO INC runs the higher net margin — 34.5% vs 5.3%, a 29.2% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.
GRDN vs WSBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $257.2M |
| Net Profit | $20.9M | $88.6M |
| Gross Margin | 21.5% | — |
| Operating Margin | 7.7% | — |
| Net Margin | 5.3% | 34.5% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 54.4% |
| EPS (diluted) | — | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $257.2M | ||
| Q4 25 | $397.6M | $265.6M | ||
| Q3 25 | $377.4M | $261.6M | ||
| Q2 25 | $344.3M | $260.7M | ||
| Q1 25 | $329.3M | $193.2M | ||
| Q4 24 | — | $162.9M | ||
| Q3 24 | $314.4M | $150.8M | ||
| Q2 24 | — | $147.9M |
| Q1 26 | — | $88.6M | ||
| Q4 25 | $20.9M | $91.1M | ||
| Q3 25 | $9.8M | $83.6M | ||
| Q2 25 | $9.0M | $57.4M | ||
| Q1 25 | $9.4M | $-9.0M | ||
| Q4 24 | — | $49.6M | ||
| Q3 24 | $-122.0M | $37.3M | ||
| Q2 24 | — | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 43.2% | ||
| Q3 25 | 4.3% | 39.5% | ||
| Q2 25 | 3.7% | 27.2% | ||
| Q1 25 | 3.9% | -5.0% | ||
| Q4 24 | — | 38.0% | ||
| Q3 24 | -33.3% | 29.7% | ||
| Q2 24 | — | 23.7% |
| Q1 26 | — | 34.5% | ||
| Q4 25 | 5.3% | 34.3% | ||
| Q3 25 | 2.6% | 31.9% | ||
| Q2 25 | 2.6% | 22.0% | ||
| Q1 25 | 2.9% | -4.7% | ||
| Q4 24 | — | 30.5% | ||
| Q3 24 | -38.8% | 24.7% | ||
| Q2 24 | — | 19.5% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | — | $0.97 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.57 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $0.72 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | — | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | — |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $4.1B |
| Total Assets | $412.7M | $27.5B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $65.6M | $956.1M | ||
| Q3 25 | $36.5M | $1.0B | ||
| Q2 25 | $18.8M | $1.2B | ||
| Q1 25 | $14.0M | $1.1B | ||
| Q4 24 | — | $568.1M | ||
| Q3 24 | $37.2M | $620.9M | ||
| Q2 24 | — | $486.8M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $4.1B | ||
| Q4 25 | $217.9M | $4.0B | ||
| Q3 25 | $195.5M | $4.1B | ||
| Q2 25 | $179.7M | $3.8B | ||
| Q1 25 | $163.2M | $3.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $133.9M | $2.8B | ||
| Q2 24 | — | $2.5B |
| Q1 26 | — | $27.5B | ||
| Q4 25 | $412.7M | $27.7B | ||
| Q3 25 | $390.0M | $27.5B | ||
| Q2 25 | $356.3M | $27.6B | ||
| Q1 25 | $334.0M | $27.4B | ||
| Q4 24 | — | $18.7B | ||
| Q3 24 | $348.0M | $18.5B | ||
| Q2 24 | — | $18.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $34.6M | $290.4M | ||
| Q3 25 | $28.2M | $116.9M | ||
| Q2 25 | $19.9M | $105.0M | ||
| Q1 25 | $17.6M | $-26.4M | ||
| Q4 24 | — | $211.0M | ||
| Q3 24 | — | $60.7M | ||
| Q2 24 | — | $18.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $280.0M | ||
| Q3 25 | $24.2M | $114.9M | ||
| Q2 25 | — | $98.3M | ||
| Q1 25 | — | $-30.7M | ||
| Q4 24 | — | $200.7M | ||
| Q3 24 | — | $56.9M | ||
| Q2 24 | — | $17.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 105.4% | ||
| Q3 25 | 6.4% | 43.9% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | -15.9% | ||
| Q4 24 | — | 123.2% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 11.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.9% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | 3.19× | ||
| Q3 25 | 2.87× | 1.40× | ||
| Q2 25 | 2.21× | 1.83× | ||
| Q1 25 | 1.86× | — | ||
| Q4 24 | — | 4.25× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
WSBC
| Net Interest Income | $215.4M | 84% |
| Noninterest Income | $41.8M | 16% |
